Effect of calcitriol treatment on arterial stiffness in people with type 2 diabetes and stage 3 chronic kidney disease.


Journal

British journal of clinical pharmacology
ISSN: 1365-2125
Titre abrégé: Br J Clin Pharmacol
Pays: England
ID NLM: 7503323

Informations de publication

Date de publication:
01 2023
Historique:
received: 30 06 2022
accepted: 01 08 2022
pubmed: 10 8 2022
medline: 22 12 2022
entrez: 9 8 2022
Statut: ppublish

Résumé

Active vitamin D deficiency is associated with increased aortic-pulse wave velocity (Ao-PWV) in people with type 2 diabetes (T2DM) and chronic kidney disease (CKD). There are no randomised controlled trials investigating the effect of active vitamin D treatment on Ao-PWV in people with T2DM and CKD. A 48-week duration single-centre randomised double-blind parallel-group trial examined the impact of oral 1,25 dihydroxyvitamin D (calcitriol 0.25 mcg OD) as compared to placebo on a primary endpoint of Ao-PWV. People with T2DM and stable stage 3 CKD with intact parathyroid hormone (iPTH) level >30 pg/mL were eligible. In total, 127 (70% male) people were randomised (calcitriol n = 64 or placebo n = 63). There was no change in Ao-PWV observed, mean ± standard deviation (SD), in the calcitriol group of 11.79 (±2.5) to 12.08 (3.0) m/s as compared to 10.90 (±2.4) to 11.39 (±2.6) m/s with placebo. The between-treatment group adjusted mean (95% confidence interval [(CI]] change was 0.23 (-0.58 to 1.05) m/s, P = .57. No effect of calcitriol was observed on central arterial pressures, albuminuria, serum calcium or phosphate levels. However, iPTH fell with calcitriol treatment (mean [95% CI] between-group difference of -27.8 (-42.3 to -13.2) pg/mL, P < .001. In T2DM and stage 3 CKD, calcitriol as compared to placebo does not improve Ao-PWV or other markers of arterial stiffness. Our study does not provide evidence for the use of active vitamin D for improving arterial stiffness in T2DM with stage 3 CKD.

Identifiants

pubmed: 35942813
doi: 10.1111/bcp.15484
pmc: PMC10087300
doi:

Substances chimiques

Calcitriol FXC9231JVH
Vitamin D 1406-16-2

Types de publication

Randomized Controlled Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

279-289

Subventions

Organisme : Diabetes UK
ID : 09/0003886
Pays : United Kingdom

Informations de copyright

© 2022 The Authors. British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society.

Références

PLoS One. 2014 Jul 09;9(7):e99461
pubmed: 25006678
Am J Kidney Dis. 2005 Mar;45(3):494-501
pubmed: 15754271
Atherosclerosis. 2015 Dec;243(2):395-401
pubmed: 26520892
Kidney Int. 2005 Nov;68(5):1973-81
pubmed: 16221197
Clin J Am Soc Nephrol. 2021 Aug;16(8):1201-1209
pubmed: 34362787
Eur J Clin Nutr. 2016 Feb;70(2):274-6
pubmed: 26350392
Pediatr Nephrol. 2016 Feb;31(2):267-77
pubmed: 26432706
Front Cardiovasc Med. 2018 Jul 12;5:87
pubmed: 30050908
Kidney Dis (Basel). 2019 Mar;5(2):59-68
pubmed: 31019920
J Am Heart Assoc. 2017 Mar 30;6(4):
pubmed: 28360227
Kidney Int. 2017 Jul;92(1):26-36
pubmed: 28646995
Cardiovasc Diabetol. 2021 Jan 7;20(1):14
pubmed: 33413348
Clin J Am Soc Nephrol. 2008 Nov;3(6):1800-6
pubmed: 18922995
J Am Soc Nephrol. 2008 Aug;19(8):1509-19
pubmed: 18448587
Arch Intern Med. 2008 Feb 25;168(4):397-403
pubmed: 18299495
N Engl J Med. 2004 Sep 23;351(13):1296-305
pubmed: 15385656
J Am Soc Nephrol. 2008 Aug;19(8):1613-9
pubmed: 18463168
J Am Heart Assoc. 2018 May 30;7(11):
pubmed: 29848497
Am J Nephrol. 2013;37(3):239-48
pubmed: 23467111
Microcirculation. 2016 Jan;23(1):53-61
pubmed: 26749451
J Steroid Biochem Mol Biol. 2020 Apr;198:105561
pubmed: 31809869
Clin J Am Soc Nephrol. 2011 Jan;6(1):50-62
pubmed: 20876671
Nephrol Dial Transplant. 1998 May;13(5):1234-41
pubmed: 9623560
J Am Soc Nephrol. 2007 Feb;18(2):613-20
pubmed: 17202417
Calcif Tissue Int. 1987 Aug;41(2):112-4
pubmed: 2820558
Clin J Am Soc Nephrol. 2013 Nov;8(11):1899-905
pubmed: 23929932
J Am Soc Nephrol. 2005 Apr;16(4):1069-75
pubmed: 15743996
Clin Endocrinol (Oxf). 2016 May;84(5):645-57
pubmed: 26824510
Hypertension. 2003 Dec;42(6):1206-52
pubmed: 14656957
J Am Soc Nephrol. 2017 Oct;28(10):3100-3108
pubmed: 28667080
J Am Soc Nephrol. 2008 Aug;19(8):1442-3
pubmed: 18614769
Circulation. 2001 Feb 20;103(7):987-92
pubmed: 11181474
PLoS One. 2014 Mar 19;9(3):e91363
pubmed: 24646518
Nephrol Dial Transplant. 2006 Jan;21(1):88-92
pubmed: 16221715
Kidney Int. 2008 Jan;73(2):163-71
pubmed: 17928826
Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1377-1379
pubmed: 28784658
Diabet Med. 2007 Apr;24(4):364-9
pubmed: 17335468
Hypertension. 2008 Jun;51(6):1617-23
pubmed: 18426991
Lancet. 2010 Nov 6;376(9752):1521-2
pubmed: 21055802
J Am Heart Assoc. 2017 Oct 24;6(10):
pubmed: 29066449
Clin Biochem. 2017 Dec;50(18):1222-1227
pubmed: 28912096
Scand Cardiovasc J. 2016 Aug;50(4):230-5
pubmed: 27101968
J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):473-6
pubmed: 17197173
Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1447-1460
pubmed: 28550081
Br J Clin Pharmacol. 2023 Jan;89(1):279-289
pubmed: 35942813
Nephrol Dial Transplant. 2016 Jul;31(7):1036-43
pubmed: 25858586
Kidney Int. 2007 Jan;71(1):31-8
pubmed: 17091124
J Hypertens. 2010 Jan;28(1):163-9
pubmed: 19927012
Eur Heart J. 2006 Nov;27(21):2588-605
pubmed: 17000623

Auteurs

Janaka Karalliedde (J)

School of Cardiovascular and Metabolic Medicine and Sciences, King's College London, London, UK.

Nikolaos Fountoulakis (N)

School of Cardiovascular and Metabolic Medicine and Sciences, King's College London, London, UK.

Antonella Corcillo (A)

School of Cardiovascular and Metabolic Medicine and Sciences, King's College London, London, UK.

Giuseppe Maltese (G)

School of Cardiovascular and Metabolic Medicine and Sciences, King's College London, London, UK.

Maria Flaquer (M)

School of Cardiovascular and Metabolic Medicine and Sciences, King's College London, London, UK.

Dimitra Stathi (D)

School of Cardiovascular and Metabolic Medicine and Sciences, King's College London, London, UK.

Anastasios Mangelis (A)

School of Population Health & Environmental Sciences, King's College London, London, UK.

Angeliki Panagiotou (A)

School of Cardiovascular and Metabolic Medicine and Sciences, King's College London, London, UK.

Salma Ayis (S)

School of Population Health & Environmental Sciences, King's College London, London, UK.

Stephen Thomas (S)

School of Cardiovascular and Metabolic Medicine and Sciences, King's College London, London, UK.

Luigi Gnudi (L)

School of Cardiovascular and Metabolic Medicine and Sciences, King's College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH